Tuesday, February 16, 2016
Pfizer, Allergan say combined drug pipeline 'underappreciated'
NEW YORK (Reuters) - The research chiefs of betrothed drugmakers Pfizer Inc and Allergan say the proposed combination of their experimental drugs deserves more credit, including potential blockbuster treatments for schizophrenia and depression.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment